ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | ![](/images/27280/ihc_cell_selected_60x60.jpg) | ![](/images/28409/61493_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images/4307/ihc_cell_selected_60x60.jpg) | ![](/images/23884/54930_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
ADK | Adenosine kinase | Disease related genes Enzymes FDA approved drug targets
| ![](/images/38409/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/38391/80914_A_3_7_rna_selected_60x60.jpg) | Expressed in all |
APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/2564/7318_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/13462/28449_B_2_4_rna_selected_60x60.jpg) | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | ![](/images/41937/90336_B_1_6_rna_selected_60x60.jpg) | Expressed in all |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | ![](/images/17258/ihc_cell_selected_60x60.jpg) | ![](/images/11089/39733_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CAT | Catalase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images/1515/ihc_cell_selected_60x60.jpg) | ![](/images/55838/135651_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/12023/30143_B_7_4_rna_selected_60x60.jpg) | Group enriched |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | ![](/images/8835/24151_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
CPT2 | Carnitine palmitoyltransferase 2 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | ![](/images/28201/59343_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
CYP51A1 | Cytochrome P450, family 51, subfamily A, polypeptide 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/41325/88210_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
DHODH | Dihydroorotate dehydrogenase (quinone) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/10123/37043_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | ![](/images/5876/14024_A_7_1_rna_selected_60x60.jpg) | Expressed in all |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/9426/25394_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | ![](/images/18530/41188_B_6_4_rna_selected_60x60.jpg) | Tissue enhanced |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/20416/45830_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/6461/17488_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
FDPS | Farnesyl diphosphate synthase | Enzymes FDA approved drug targets Plasma proteins
| ![](/images/28200/ihc_selected_60x60.jpg) | | ![](/images/28200/ihc_cell_selected_60x60.jpg) | ![](/images/28200/59738_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| ![](/images/10886/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/10886/26033_A_2_1_rna_selected_60x60.jpg) | Mixed |
FLT4 | Fms-related tyrosine kinase 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Mixed |
GANAB | Glucosidase, alpha; neutral AB | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | ![](/images/26874/57339_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
GSR | Glutathione reductase | Cancer-related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | ![](/images/8632/26476_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
HDAC1 | Histone deacetylase 1 | Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/5017/18247_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
HDAC2 | Histone deacetylase 2 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | ![](/images/5054/17524_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
HDAC3 | Histone deacetylase 3 | Enzymes FDA approved drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/5583/18272_B_7_2_rna_selected_60x60.jpg) | Expressed in all |
HDAC6 | Histone deacetylase 6 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | ![](/images/3714/ihc_cell_selected_60x60.jpg) | ![](/images/26321/57610_A_3_2_rna_selected_60x60.jpg) | Expressed in all |
IDE | Insulin-degrading enzyme | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| ![](/images/63478/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/63478/143062_B_7_6_rna_selected_60x60.jpg) | Expressed in all |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | ![](/images/1249/ihc_cell_selected_60x60.jpg) | ![](/images/4447/13182_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
IMPDH1 | IMP (inosine 5'-monophosphate) dehydrogenase 1 | Disease related genes Enzymes FDA approved drug targets
| ![](/images/1400/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/1400/5503_B_7_4_rna_selected_60x60.jpg) | Expressed in all |
IMPDH2 | IMP (inosine 5'-monophosphate) dehydrogenase 2 | Enzymes FDA approved drug targets Plasma proteins
| ![](/images/1400/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/1400/5500_A_9_5_rna_selected_60x60.jpg) | Expressed in all |
INSR | Insulin receptor | CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| ![](/images/36302/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/36302/112004_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | ![](/images/26430/ihc_cell_selected_60x60.jpg) | ![](/images/3834/10782_A_2_6_rna_selected_60x60.jpg) | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | ![](/images/3835/11076_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/5700/20814_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
MAPK3 | Mitogen-activated protein kinase 3 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets RAS pathway related proteins
| | | ![](/images/2683/ihc_cell_selected_60x60.jpg) | ![](/images/5700/20814_B_7_4_rna_selected_60x60.jpg) | Expressed in all |
MET | Met proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| ![](/images/5282/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/5282/15801_A_8_1_rna_selected_60x60.jpg) | Mixed |
METAP2 | Methionyl aminopeptidase 2 | Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/13025/28837_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
MMP10 | Matrix metallopeptidase 10 (stromelysin 2) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| ![](/images/2159/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/2159/6304_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
MMP15 | Matrix metallopeptidase 15 (membrane-inserted) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| ![](/images/40390/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/40390/92316_A_3_6_rna_selected_60x60.jpg) | Mixed |
MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase | Disease related genes Enzymes FDA approved drug targets Predicted secreted proteins
| ![](/images/44474/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/44474/99154_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/28407/59771_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
PDE3A | Phosphodiesterase 3A, cGMP-inhibited | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| ![](/images/14492/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/14492/34301_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
PDXK | Pyridoxal (pyridoxine, vitamin B6) kinase | Enzymes FDA approved drug targets Plasma proteins
| ![](/images/30196/ihc_selected_60x60.jpg) | | | ![](/images/30196/65230_B_5_2_rna_selected_60x60.jpg) | Expressed in all |
PLA2G4A | Phospholipase A2, group IVA (cytosolic, calcium-dependent) | Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/10050/28034_B_9_2_rna_selected_60x60.jpg) | Mixed |
POLA1 | Polymerase (DNA directed), alpha 1, catalytic subunit | Enzymes FDA approved drug targets
| | | ![](/images/2947/ihc_cell_selected_60x60.jpg) | ![](/images/2947/8235_A_7_4_rna_selected_60x60.jpg) | Expressed in all |
POLE | Polymerase (DNA directed), epsilon, catalytic subunit | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
POLE2 | Polymerase (DNA directed), epsilon 2, accessory subunit | Enzymes FDA approved drug targets
| ![](/images/27555/ihc_selected_60x60.jpg) | | ![](/images/27555/ihc_cell_selected_60x60.jpg) | ![](/images/27555/58602_B_8_1_rna_selected_60x60.jpg) | Mixed |
PRDX5 | Peroxiredoxin 5 | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | ![](/images/8661/22812_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
PRKAA1 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | Enzymes FDA approved drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/5050/17832_B_9_1_rna_selected_60x60.jpg) | Expressed in all |